Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Fulcrum Therapeutics Inc. (FULC)

   0 (0%) 12-31 19:00
Open: Pre. Close:
High: Low:
Volume: Market Cap: 0M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 8.011 - 8.056 8.056 - 8.097
Low: 7.484 - 7.542 7.542 - 7.594
Close: 7.845 - 7.93 7.93 - 8.008

Technical analysis

as of: 2020-10-01 3:33:59 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 9.58     One year: 10.44
Support: Support1: 7.01    Support2: 5.83
Resistance: Resistance1: 8.20    Resistance2: 8.94
Pivot: 8.04
Moving Average: MA(5): 7.90     MA(20): 7.97
MA(100): 14.36     MA(250): 13.39
MACD: MACD(12,26): -0.50     Signal(9): -0.67
Stochastic oscillator: %K(14,3): 22.30     %D(3): 27.79
RSI: RSI(14): 41.72
52-week: High: 22.96  Low: 4.37  Change(%): 17.4
Average Vol(K): 3-Month: 21191  10-Days: 28019

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
FULC has closed above bottom band by 31.9%. Bollinger Bands are 79.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to FULC's normal range. The bands have been in this narrow range for 22 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 01 Oct 2020
Fulcrum Therapeutics Announces Multiple Presentations During the Virtual 25th International Congress of the World Muscle Society - GlobeNewswire

Fri, 25 Sep 2020
Fulcrum Therapeutics Announces Preclinical Proof-of-Concept Data for FTX-6058 at the Virtual 14th Annual Sickle Cell Disease Research & Educational Symposium and 43rd National Sickle Cell Disease Scientific Meeting - GlobeNewswire

Fri, 25 Sep 2020
Do Traders View Fulcrum Therapeutics Inc (FULC) Stock's Current Trend Positively? - InvestorsObserver

Mon, 21 Sep 2020
Steven Cohen Ups Bets on Dave & Busters, Fulcrum Therapeutics - Yahoo Finance

Tue, 08 Sep 2020
Fulcrum Therapeutics to Participate in Upcoming Investor Conferences - Yahoo Finance

Wed, 02 Sep 2020
What is the Market's View on Fulcrum Therapeutics Inc (FULC) Stock's Price and Volume Trends - InvestorsObserver

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Neutral
Return on Assets: Neutral Price to Earnings: Neutral
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Shares Out. (M) 27
Shares Float (M) 14
% Held by Insiders 16.33
% Held by Institutions 67.19
Shares Short (K) 745
Shares Short P. Month (K) 499

Stock Financials

EPS -14.920
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 4.530
Profit Margin
Operating Margin -2480.58
Return on Assets (ttm) -40.6
Return on Equity (ttm) -76.1
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share 0.100
EBITDA (p.s.) -2.408
Qtrly Earnings Growth
Operating Cash Flow (M) -47
Levered Free Cash Flow (M) -29

Stock Valuations

PE Ratio -0.52
PEG Ratio
Price to Book value 1.73
Price to Sales 78.16
Price to Cash Flow -4.59

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.